Autologous bone versus calcium-phosphate ceramics in treatment of experimental bone defects

被引:61
作者
Bloemers, FW
Blokhuis, TJ
Patka, P
Bakker, FC
Wippermann, BW
Haarman, HJTM
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Surg Traumatol, NL-1081 HV Amsterdam, Netherlands
[2] Hannover Med Sch, Dept Surg Traumatol, Hannover, Germany
关键词
calcium phosphates; bone defect; autollogous bone; experimental study;
D O I
10.1002/jbm.b.10045
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Autologous bone grafting is currently considered the treatment of choice for correction of large bone defects. However, to avoid morbidity associated with autologous bone harvesting many artificial bone-substitute materials have been developed over the years. A new generation of resorbable materials is emerging, with promising results so far. In order to investigate the possibility to use one of these new materials as an alternative with better results than hydroxyapatite, an experimental study was performed. A new resorbable calcium phosphate particles and paste forms, the latter of which hardens in situ after application. In 28 sheep, a 3-cm segmental tibial defect was made and intramedullary fixed by an interlocking nail. Twelve weeks after defect filling, radiological, biomechanical, and histological examinations were performed. Mean radiographic and biomechanical tests results were compared with the Mann-Whitney test. Significance was set at p < 0.05. Radiographically, the resorbable paste group performed better than all other groups. Biomechanical investigations showed a higher torsional stiffness (p = 0.049) for the resorbable calcium-phosphate paste group in comparison with autollogous bone. On histological examination, no adverse effects were observed in the calcium-phosphate groups. Resorbtion by osteoclasts was seen in the resorbable implants. In conclusion, the current study shows an advantageous radiological and mechanical outcome for resorbable calcium phosphates. This indicates that these new materials might be a potential alternative for autologous bone grafting in humans. (C) 2003 Wiley Periodicals, Inc.
引用
收藏
页码:526 / 531
页数:6
相关论文
共 32 条
[11]  
GOAD MEP, 1997, J BONE MINER RES S, V12, P518
[12]  
Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO
[13]  
2-9
[14]  
GROSS D, 1986, UNFALLCHIRURG, V83, P339
[15]  
Hamanishi C, 1996, J BIOMED MATER RES, V32, P383, DOI 10.1002/(SICI)1097-4636(199611)32:3<383::AID-JBM11>3.0.CO
[16]  
2-I
[17]  
Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO
[18]  
2-P
[19]  
JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
[20]   α-BSM®:: A biomimetic bone substitute and drug delivery vehicle [J].
Lee, DD ;
Tofighi, A ;
Aiolova, M ;
Chakravarthy, P ;
Catalano, A ;
Majahad, A ;
Knaack, D .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1999, (367) :S396-S405